Results 91 to 100 of about 10,548 (182)

Cardiac‐specific Kv1.1 deficiency alters cardiomyocyte electrophysiology without modifying overall cardiac function or arrhythmia susceptibility

Experimental Physiology, Volume 111, Issue 3, Page 1120-1133, 1 March 2026.
Abstract The leading cause of epilepsy‐related mortality is sudden unexpected death in epilepsy (SUDEP), resulting from seizure‐induced cardiorespiratory arrest by mechanisms that remain unresolved. Mutations in ion channel genes expressed in both brain and heart represent SUDEP risk factors because they can disrupt neural and cardiac rhythms ...
Kelsey Halvorson, Man Si, Krystle Trosclair, Ellen Aughenbaugh, Maxine Parkinson, Nicole M. Gautier‐Hall, Megan Watts, Frederica Kizek, Md. Shenuarin Bhuiyan, Paari Dominic, Kathryn A. Hamilton, Edward Glasscock   +11 more
wiley   +1 more source

Development of a hub-and-spoke durable left ventricular assist device program in Brazil, a middle-income country

JHLT Open
Background: In middle-income countries, costs limit widespred use of left ventricular assist device (LVAD) as a strategy for end-stage heart failure. We aim to describe the experience of a LVAD program in a middle-income country in a hub-and-spoke model.
Deborah de Sá Pereira Belfort, Bruno Biselli, Mônica Samuel Avila, Renata Lopes Hames, Stephanie Itala Rizk, Fabrício Canova Calil, Bruna Carneiro Oliveira, Filomena Regina Barbosa Gomes Galas, Ludhmila Abrahão Hajjar, Nadine Oliveira Clausell, Livia Adams Goldraich, Ramez Anbar, Edimar Alcides Bocchi, Tadeu Thomé, Roberto Kalil Filho, Paulo Manuel Pêgo-Fernandes, Fabio Biscegli Jatene, Silvia Moreira Ayub-Ferreira   +17 more
doaj   +1 more source

Development of a quality of life measure for left ventricular assist device recipients using a mixed methods approach

ESC Heart Failure
Background Left ventricular assist device (LVAD) recipients report symptom improvement but find adjusting to life with the LVAD challenging. These challenges are unique, and existing patient‐reported outcome measures (PROMs) do not reflect their ...
Anita L. Slade, Christel McMullan, M. Sayeed Haque, Stephen Griffith, Laura Marley, David Quinn, Margaret E. O'Hara, Mike Horton, Melanie J. Calvert, Hoong Sern Lim, Deirdre A. Lane   +10 more
doaj   +1 more source

Clinical management of aortic valve regurgitation after left ventricular assist device implantation: prediction, assessment, and treatment strategies. [PDF]

Front Cardiovasc Med
Li S, Xu Y, Zhang S, Han Z, Liu X.
europepmc   +1 more source

Financial Implications of GI Bleeding in Patients with LVAD: An Analysis from the US National Inpatient Sample Trends. [PDF]

Med Sci (Basel)
Basetty S, Philip AM, Parlapalli RSR, Gopireddy NSR, Akula N, Yeddula K, Kaasam S, George LJ, Varma R, Mautong H, John K, Mishra A.   +11 more
europepmc   +1 more source

Left ventricular assist device utilization across the different regions of the Netherlands. [PDF]

Neth Heart J
Drost VCE, Wösten M, Otterspoor LC, Damman K, Tops LF, Gianoli M, Kuijpers M, Palmen M, Sjatskig J, Yazdanbakhsh AP, Caliskan K, Van Laake LW.   +11 more
europepmc   +1 more source

Magnetically levitated LVAD gains MOMENTUM [PDF]

Nature Reviews Cardiology, 2019
openaire   +2 more sources

Comparison of the burden of ventricular arrhythmias before and after left ventricular assist device implantation: A retrospective observational study. [PDF]

Medicine (Baltimore)
Park YS, Kim AR, Hyun J, Lee SE, Jung SH, Kim MS.   +5 more
europepmc   +1 more source

Cardiac Rehabilitation After Left Ventricular Assist Device Implantation: A Narrative Review. [PDF]

J Clin Med
Gravino R, Falco L, Catapano D, Amarelli C, Valente F, Verrengia M, Marra C, Di Lorenzo E, Di Silverio P, Kittleson M, Masarone D.   +10 more
europepmc   +1 more source

Routine Echocardiographic Assessment in LVAD Patients-A Structured Approach to Acquisition and Interpretation. [PDF]

J Cardiovasc Dev Dis
Merke N, Schoenrath F, Potapov E, Knierim J.   +3 more
europepmc   +1 more source